And it was originally developed, the GLP-1 receptor agonist, so the medication itself was originally developed for diabetics to help the body produce more insulin, reduce the amount of sugar, of blood sugar, I should say, which can be really bad for diabetics
It is well-tolerated and its benefits are supported in the research
In 2023, following numerous consumer reports, the FDA updated the Ozempic label to include a warning about ileus
The definitive test is an IGF-1 blood draw at baseline and 8-12 weeks
The dose is high enough to align with many common study protocols, while still allowing users to increase intake if appropriate
Meanwhile, the more obvious association in men has some consistency with higher CVD risk and higher carnitine in men than women [48]